Secondary B-Cell Acute Lymphoblastic Leukemia Following Multiple Myeloma Treatment

Clinical Laboratory
|July 7, 2026
PubMed
Summary

Secondary B-cell acute lymphoblastic leukemia (B-ALL) is a rare complication after multiple myeloma (MM) treatment. Bortezomib therapy and autologous stem cell transplant for MM may increase the risk of developing secondary B-ALL.